menu
    • menu

    Company profile for Novigenix SA

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Novigenix is a molecular diagnostic company that harnesses its powerful Immuno-Transcriptomics technology and its proprietary data to disrupt how cancer is detected and to measure patient’s response to therapy. Over the last 10 years we experienced a significant increase of scientific evidence of the involvement of the host response within oncology. As a company we have spent many years on the development of our host immune ...
    Novigenix is a molecular diagnostic company that harnesses its powerful Immuno-Transcriptomics technology and its proprietary data to disrupt how cancer is detected and to measure patient’s response to therapy. Over the last 10 years we experienced a significant increase of scientific evidence of the involvement of the host response within oncology. As a company we have spent many years on the development of our host immune response platform within colon cancer. Together with our collaborators we have developed, launched and commercialized the first immuno-transcriptomic product on the market.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Novigenix SASwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Route de la Corniche 3 Bâtiment SE-A CH-1066 Epalinges
    Telephone
    Telephone
    +41 (0)21 552 07 30
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://novigenix.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/novigenix
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novigenix Announces First Closing of its $20M Series B
    Novigenix Announces First Closing of its $20M Series B

    16 Nov 2022

    // ACCESSWIRE

    https://www.accesswire.com/726313/Novigenix-Announces-First-Closing-of-its-20M-Series-B

    ACCESSWIRE
    16 Nov 2022
    Share Share
    Novigenix Announces Discovery of Liquid Biopsy Immunotherapy Response Biomarkers
    Novigenix Announces Discovery of Liquid Biopsy Immunotherapy Response Biomarkers

    08 Sep 2022

    // ACCESSWIRE

    https://www.accesswire.com/715303/Novigenix-Announces-Discovery-of-Liquid-Biopsy-Immunotherapy-Response-Biomarkers-in-Metastatic-Melanoma

    ACCESSWIRE
    08 Sep 2022
    Share Share
    Novigenix and Philips Sign Technology License Agreement
    Novigenix and Philips Sign Technology License Agreement

    09 Mar 2022

    // ACCESSWIRE

    https://www.accesswire.com/692100/Novigenix-and-Philips-Sign-Technology-License-Agreement-for-Prostate-Cancer-Precision-Oncology-Products

    ACCESSWIRE
    09 Mar 2022
    Share Share
    Novigenix-Led Consortium Secures Eurostars Funding
    Novigenix-Led Consortium Secures Eurostars Funding

    21 Jan 2020

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20200120005298/en

    BUSINESS WIRE
    21 Jan 2020
    Share Share
    Novigenix and RadioMedix to Develop Neuroendocrine Cancer
    Novigenix and RadioMedix to Develop Neuroendocrine Cancer

    15 Oct 2019

    // BIOSPACE

    https://www.biospace.com/article/releases/novigenix-and-radiomedix-to-develop-neuroendocrine-cancer-precision-diagnostic-test/?s=95

    BIOSPACE
    15 Oct 2019
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search